Day: March 2, 2026

us corporate news

Xeris Biopharma Holdings, Inc. 2025 Earnings Release and SEC 8-K Filing Details

Minichart

March 2, 2026

Xeris Biopharma Reports Record Revenue for Q4 and Full Year ...

Continue Reading 0

us corporate news

enCore Energy Executive Chair William M. Sheriff Retires, Becomes Chairman Emeritus and Joins Verdera Energy Corp. as Executive Chair

Minichart

March 2, 2026

enCore Energy Corp. Announces Executive Leadership Changes a...

Continue Reading 0

us corporate news

Sionna Therapeutics Reports Q4 and Full Year 2025 Financial Results and Provides Update on Cystic Fibrosis Trial Progress

Minichart

March 2, 2026

Sionna Therapeutics Reports Q4 and Full Year 2025 Financial ...

Continue Reading 0

us corporate news

Astrana Health Reports Record 2025 Revenue, 2026 Guidance, and Expanded Share Repurchase Program

Minichart

March 2, 2026

Astrana Health, Inc. Delivers Record 2025 Results, Expands B...

Continue Reading 0

us corporate news

Sealed Air Q4 & Full Year 2025 Results: Financial Highlights, CD&R Acquisition, Net Sales & Cash Flow Analysis

Minichart

March 2, 2026

Sealed Air Reports Q4 and Full Year 2025 Results; CD&R Acqui...

Continue Reading 0

us corporate news

Apogee Therapeutics Reports 2025 Financial Results and Pipeline Progress for Zumilokibart in Atopic Dermatitis, Asthma, and Expansion Indications 12

Minichart

March 2, 2026

Apogee Therapeutics Pipeline Progress & Full Year 2025 Finan...

Continue Reading 0

us corporate news

U.S. Federal Income Tax Considerations for Non-U.S. Holders of Hawaiian Electric Industries Common Stock

Minichart

March 2, 2026

Key U.S. Federal Income Tax Considerations for Non-U.S. Hold...

Continue Reading 0

us corporate news

CubeSmart Investor Presentation 2026: Growth Strategies, Portfolio Performance, and Financial Highlights

Minichart

March 2, 2026

Executive Summary CubeSmart, a leading self-storage REI...

Continue Reading 0

us corporate news

DNA X, Inc. (Formerly Sonim Technologies) Files 8-K/A on Acquisition and Company Details – SEC Filing March 2026

Minichart

March 2, 2026

DNA X, Inc. Files Amendment No. 1 to Form 8-K/A – Key Transa...

Continue Reading 0

us corporate news

Humana Inc. Form 8-K Filing Summary for March 2, 2026 – Company Details, Stock Information, and XBRL Data

Minichart

March 2, 2026

Humana Inc. Reaffirms 2026 Earnings Guidance in Investor Mee...

Continue Reading 0